Almost 70 years after the discovery of the respiratory syncytial virus (RSV), vaccines and preventive treatments are giving babies a chance to beat the potentially deadly childhood infection.

About 8 in 10 infants received respiratory syncytial virus protection during the 2023 to 2024 season, according to study findings.

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...

Explore the uptake of maternal RSV vaccination and infant protection trends during the 2023-2024 RSV season, focusing on ...

Respiratory syncytial virus (RSV) leads to over 30 million severe respiratory infections, 3.5 million hospitalizations, and 100,000 deaths among children under five each year globally. Nearly half of ...

The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels of flu and RSV activity in wastewater. In emergency room visits, the CDC ...

RSV is a common, but highly infectious ... He said while most babies and children do not need hospital treatment, the younger the child, the more likely it is for them to need hospitalisation ...

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

RSV is a common but highly infectious respiratory virus that affects the breathing system, particularly in young children and older adults. According to the Public Health Agency, there have been ...

Lehi Free Press “This year has been particularly bad for the flu. We haven’t had a season quite this bad for a couple of ...

Pregnant women across Australia will be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next month. The government's $174.5 million investment will ...